Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.
about
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trialsAdvanced magnetic resonance imaging methods for planning and monitoring radiation therapy in patients with high-grade gliomaMR imaging features of high-grade gliomas in murine models: how they compare with human disease, reflect tumor biology, and play a role in preclinical trialsImaging-based tumor treatment response evaluation: review of conventional, new, and emerging conceptsUsing magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approachesClinical applications for diffusion magnetic resonance imaging in radiotherapyDynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastomaThe comprehensive neuro-oncology data repository (CONDR): a research infrastructure to develop and validate imaging biomarkersDW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastomaSensitivity of MRI tumor biomarkers to VEGFR inhibitor therapy in an orthotopic mouse glioma modelPerifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastomaDiffusion imaging for therapy response assessment of brain tumorUltrasonic spectrum analysis for in vivo characterization of tumor microstructural changes in the evaluation of tumor response to chemotherapy using diagnostic ultrasound.Comparison between diffusion-weighted imaging, T2-weighted, and postcontrast T1-weighted imaging after MR-guided, high intensity, focused ultrasound treatment of uterine leiomyomata: preliminary results.Optimal experimental design for filter exchange imaging: Apparent exchange rate measurements in the healthy brain and in intracranial tumorsParameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy.Diffusion-weighted MRI as a biomarker for treatment response in gliomaFractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy.Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy.Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.Non-Gaussian water diffusion in aging white matter.Apparent diffusion coefficient is a prognostic factor of head and neck squamous cell carcinoma treated with radiotherapy.Imaging biomarkers for antiangiogenic therapy in malignant gliomas.Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas.Imaging mimics of primary malignant tumors of the central nervous system (CNS).Advanced magnetic resonance imaging of the physical processes in human glioblastoma.Correlation of ADC value with pathologic indexes in colorectal tumor homografts in Balb/c mouse.Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics.Practical estimate of gradient nonlinearity for implementation of apparent diffusion coefficient bias correction.Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.Between-Scanner and Between-Visit Variation in Normal White Matter Apparent Diffusion Coefficient Values in the Setting of a Multi-Center Clinical Trial.Water diffusion in a rat glioma during ganciclovir-thymidine kinase gene therapy-induced programmed cell death in vivo: correlation with cell density.Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRISodium magnetic resonance imaging of chemotherapeutic response in a rat glioma.Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy.Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.Imaging in neurooncologyDynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.Application of 23Na MRI to monitor chemotherapeutic response in RIF-1 tumors.Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma.
P2860
Q26801351-414BA01A-128A-4C10-A845-CD2855DA024BQ26826862-CB653338-A73A-40DB-936A-7CB89584C31EQ26863563-28F37A13-6E32-4106-9B19-5EA5DFA3F5CDQ26863654-0F085403-DD91-455C-BC9F-014D6832BCD7Q26865120-13F61851-8F1B-499B-9E8E-F8DC80F8D175Q27005757-780ECB61-2A42-48C3-8DD7-C5A9615BC3EAQ27344690-27BBB1C7-18FB-49C5-AA9C-8FBF6B593C87Q28608269-D0DB3345-2030-48F3-BD47-39D0F1519D1DQ28730443-94EB3B4D-E31A-4CA7-88E3-978B07D68960Q28742242-3797F6CC-3ED7-40A4-A6C7-1D2AB941510DQ28743461-D1E61A06-EDBB-452C-89BD-5328FFD12DE4Q30437277-1459011F-B239-4688-AE18-23455D530207Q30452720-1014CDCB-1ED1-4B0E-850D-AFE132E9D9B5Q30474382-4DD6DDD9-2C22-47C3-8D86-2649D541DF53Q30489078-85FE094B-0281-42C3-B4B4-BD8AACF2C155Q30639288-45F2685D-BD3B-4658-A943-0DFD992ACE6EQ30660991-D533042C-9F31-4D7B-AECC-D21B7014AC01Q30666523-350988A8-2B23-442E-847F-3DC8E4A930A6Q30673119-CB4077B6-8252-49B3-A628-A86991BBEC35Q30690776-6E36C53A-F299-4F79-91E3-F69845DA2705Q30724849-4B195042-7D93-425C-B480-0EBD7D01BB9FQ30730091-B594604F-2037-4C4A-9979-03A9FCB7FF8FQ30764736-14C2653A-F5EA-403D-B12D-4AC9FF0117EAQ30775012-1A7A3CE6-E783-4D0D-93F5-A5BCDA2EE7BBQ30831008-268DFDBF-7067-4658-9C8F-B5569EC57B64Q30847284-E4F8B0FE-AEAB-4ADE-8D2F-BFC3C20E34B3Q30852947-90FE2289-32A6-4CF0-8556-7236FD00B5A9Q30870628-503675A8-949A-43DF-9DB4-A57928014C51Q30890815-DE3DC4D9-538B-4204-8631-6DB964228AA6Q30907831-8D18F5CB-49FB-475B-A132-BF26A20FB559Q30912628-32CBDF1B-68A8-4C5A-8EEE-7BFA43EF55DBQ30919446-42CDB9ED-81B5-4B6F-B6C7-FE88F1A191FFQ30930689-574C98DC-29B8-45E9-8246-DBA375CF9BBEQ30982009-A104AEC4-EBE3-49FF-8A73-61AF48F52CF7Q30983132-5EE8BC1A-C109-48D0-98D6-32FBEDE32978Q30986317-2A7F9A56-2D25-4824-BB7E-9F268CFCD469Q30989939-4730AD3C-08CF-429D-BDD3-C1A57EB421EDQ30992467-68B661A4-0871-40DC-A6E0-D5A764423090Q30994994-C0CB72B6-6BB8-4FE0-B68B-0857429957F8Q31015437-F1DD787C-897F-4242-9FCE-B2B7AF4B8A62
P2860
Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Diffusion magnetic resonance i ...... utic efficacy in brain tumors.
@ast
Diffusion magnetic resonance i ...... utic efficacy in brain tumors.
@en
type
label
Diffusion magnetic resonance i ...... utic efficacy in brain tumors.
@ast
Diffusion magnetic resonance i ...... utic efficacy in brain tumors.
@en
prefLabel
Diffusion magnetic resonance i ...... utic efficacy in brain tumors.
@ast
Diffusion magnetic resonance i ...... utic efficacy in brain tumors.
@en
P2093
P356
P1476
Diffusion magnetic resonance i ...... utic efficacy in brain tumors.
@en
P2093
A Rehemtulla
H S Greenberg
J M Taylor
L D Stegman
P L Robertson
T L Chenevert
P304
P356
10.1093/JNCI/92.24.2029
P407
P577
2000-12-01T00:00:00Z